Dr. Glen N. Barber's lab at Ohio State University studies how a protein called STING plays a key role in the immune system, particularly regarding how our bodies respond to infections and cancer. They focus on understanding the mechanisms by which STING signaling can make infected or damaged cells more recognizable to the immune system, potentially improving cancer treatment strategies. The lab's work has implications for developing more effective therapies for various health issues, including cancer and inflammatory diseases.

Dr. Harrison Kim's lab at Ohio State University focuses on improving treatment strategies for patients with borderline resectable pancreatic cancer. They utilize advanced imaging techniques, specifically dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), to evaluate how well patients respond to chemotherapy before surgical intervention. This innovative approach aims to enhance surgical outcomes and ensure patients receive the most effective therapy early in the treatment process.